mRNA-based anti-COVID-19 vaccines induced higher B cells and IgG levels than whole virus-based: A pilot study on Egyptian individuals

BackgroundB cells are critical components of vaccine-induced humoral immunity. However, circulating total B-cell measurements do not by themselves establish antigen specificity, memory differentiation, neutralizing activity, or protection. Aim: This exploratory observational study compared circulating CD19+ B-cell numbers and anti-SARS-CoV-2 spike receptor-binding domain (RBD) binding antibody levels according to COVID-19 vaccine platform and time since vaccination.MethodsSixty-one participants were included: 52 vaccinated participants and 9 non-vaccinated participants. Vaccinated participants had received Pfizer (BNT162b2), ChAdOx1 nCoV-19, or inactivated-virus vaccines (Sinopharm or Sinovac). Peripheral blood mononuclear cells were analyzed by flow cytometry using CD19 to quantify total circulating B cells, while anti-SARS-CoV-2 spike-RBD binding antibodies were measured using the Elecsys Anti-SARS-CoV-2 S assay.ResultsTotal CD19+ B-cell percentages and absolute numbers were not significantly different between the vaccinated platform groups and the non-vaccinated controls. Anti-SARS-CoV-2 spike-RBD binding antibody levels were significantly higher in vaccinated participants than in controls. The relationship between circulating CD19+ B-cell frequency and antibody concentration was weak.ConclusionThese exploratory findings suggest persistent humoral immune responses after COVID-19 vaccination but do not establish superiority of one vaccine platform. Because the study was limited by sample size, heterogeneous. vaccination histories, incomplete objective ascertainment of previous SARS-CoV-2 infection, and use of a binding-antibody assay rather than a functional neutralization assay, the findings should be interpreted as preliminary and require confirmation in larger, adequately powered studies.

Authors

Institutions

Publication Details

Journal
Human Antibodies
Published
2026-11-13
DOI
https://doi.org/10.1177/10932607261506645
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

mRNA-based anti-COVID-19 vaccines induced higher B cells and IgG levels than whole virus-based: A pilot study on Egyptian individuals

EL-Hassan M. Mokhamer, Noura E. Sanoh, Kadry Abd-El kader Moktar El-bakry, Mohamed Labib Salem et al.
3 links
Human Antibodies
SARS-CoV-2 and COVID-19 Research
article

mRNA-based anti-COVID-19 vaccines induced higher B cells and IgG levels than whole virus-based: A pilot study on Egyptian individuals

EL-Hassan M. Mokhamer, Noura E. Sanoh, Kadry Abd-El kader Moktar El-bakry, Mohamed Labib Salem, Sohaila Mohamed Khalil, Walaa G. Ahmed
article en

Abstract

BackgroundB cells are critical components of vaccine-induced humoral immunity. However, circulating total B-cell measurements do not by themselves establish antigen specificity, memory differentiation, neutralizing activity, or protection. Aim: This exploratory observational study compared circulating CD19+ B-cell numbers and anti-SARS-CoV-2 spike receptor-binding domain (RBD) binding antibody levels according to COVID-19 vaccine platform and time since vaccination.MethodsSixty-one participants were included: 52 vaccinated participants and 9 non-vaccinated participants. Vaccinated participants had received Pfizer (BNT162b2), ChAdOx1 nCoV-19, or inactivated-virus vaccines (Sinopharm or Sinovac). Peripheral blood mononuclear cells were analyzed by flow cytometry using CD19 to quantify total circulating B cells, while anti-SARS-CoV-2 spike-RBD binding antibodies were measured using the Elecsys Anti-SARS-CoV-2 S assay.ResultsTotal CD19+ B-cell percentages and absolute numbers were not significantly different between the vaccinated platform groups and the non-vaccinated controls. Anti-SARS-CoV-2 spike-RBD binding antibody levels were significantly higher in vaccinated participants than in controls. The relationship between circulating CD19+ B-cell frequency and antibody concentration was weak.ConclusionThese exploratory findings suggest persistent humoral immune responses after COVID-19 vaccination but do not establish superiority of one vaccine platform. Because the study was limited by sample size, heterogeneous. vaccination histories, incomplete objective ascertainment of previous SARS-CoV-2 infection, and use of a binding-antibody assay rather than a functional neutralization assay, the findings should be interpreted as preliminary and require confirmation in larger, adequately powered studies.

Human Antibodies
Damietta University (EG), Damanhour University (EG), Tanta University (EG), Tanta University Hospital (EG)
Academy of Scientific Research and Technology
Good health and well-being
SARS-CoV-2 and COVID-19 Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon